-
The AI-in-RWE Transparency (AIRT) Checklist: Essential and Desirable Standards for AI-Enhanced Real-World Evidence
Sep 9, 2025, 16:22 PM -
Ensuring Greater Acceptance of Minimal Residual Disease Negativity in Health Technology Assessments in Multiple Myeloma: Key Barriers and Opportunities
Sep 9, 2025, 16:22 PM -
An Interactive Tool to Select Indirect Treatment Comparison Methods for Rapid Feasibility Assessment
Sep 9, 2025, 16:22 PM -
Differences in the Reimbursement Pathway for Ultraorphan Therapies in England and Ireland
Sep 9, 2025, 16:22 PM -
Budgetary Impact of Ultra-Rare Diseases in Brazil: A Review of Decisions From the Past Five Years
Sep 9, 2025, 16:22 PM -
Comparative Effectiveness of Alectinib vs. Crizotinib as First-Line Therapy in ALK-Positive Non-Small Cell Lung Cancer: A Real-World Quasi-Experimental Study
Sep 9, 2025, 16:22 PM -
Exploring Nonproportional Hazards Multi-Level Network Meta-Regression (ML-NMR) for Survival Extrapolations in Oncology
Sep 9, 2025, 16:22 PM -
Gender Inequalities in Aortic and Mitral Valve Replacement and Repair Procedures in Germany
Sep 9, 2025, 16:22 PM -
Have Delays in Vaccine Market Access Improved in Europe and the US Over the Last Decade?
Sep 9, 2025, 16:22 PM -
From Anxiety to Hope: Understanding the Adoption of AI Counseling Tools for Anxiety Management
Sep 9, 2025, 16:22 PM -
Incidence and Prevalence of Primary Biliary Cholangitis (PBC) and Cholestatic Pruritus (CP) in Germany: Results From a Statutory Health Insurance (SHI) Claims Analysis
Sep 9, 2025, 16:22 PM -
Budget Impact of the VELYS™ Robotic-Assisted Solution Compared to Manual Procedure in Patients Undergoing Primary Total Knee Arthroplasty in France
Sep 9, 2025, 16:22 PM -
Real-life-Persistence to Antifibrotic Treatments in the French Population
Sep 9, 2025, 16:22 PM -
Methodological Insights From Recent PBAC Recommendations to Support Biosimilar Reimbursement in Australia
Sep 9, 2025, 16:22 PM -
Impact of Mucus Plugs on the Health Economic Burden in Chronic Obstructive Pulmonary Disease (COPD) Patients
Sep 9, 2025, 16:22 PM -
Comparative Efficacy and Safety of Delgocitinib, Alitretinoin, and PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema: A Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Relevance of Quality Indicators for Supporting Patients’ Choice of Hospitals: An Online Survey
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Dinutuximab Beta in the Maintenance Therapy of High-Risk Neuroblastoma in Brazil
Sep 9, 2025, 16:22 PM -
Efficacy of Pregabalin and High-Concentration (179 mg) Capsaicin Patch in Peripheral Neuropathic Pain: A Review of Studies ≥ 26 Weeks' Duration
Sep 9, 2025, 16:22 PM -
Role of Real-World Evidence (RWE) in Pricing and Reimbursement Decisions for Rare Disease in Health Technology Assessment (HTA) Submissions Across EU4 + UK
Sep 9, 2025, 16:22 PM
